Prior Authorization Workarounds for PI Medications

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | September 7, 2025 | 9 min read

Prior authorization requirements can delay medication access for personal injury patients. Learn about the common PA barriers, workaround strategies, and how pharmacy lien programs bypass these obstacles entirely.

Prior Authorization Workarounds for PI Medications

Prior authorization (PA) is one of the most frustrating obstacles in medication access. For personal injury patients who are in pain and need their medications now, being told that their prescription requires insurance company approval before it can be filled is more than an inconvenience — it is a barrier to recovery.

This guide explains what prior authorization is, why it exists, the common medications that trigger PA requirements, and — most importantly — how to get around these delays so PI patients receive timely care.

[!KEY] Pharmacy lien programs bypass prior authorization entirely because they operate outside the insurance system — there is no insurance claim, so there is no PA requirement, and the prescription is filled based on the treating physician's order.

What Is Prior Authorization?

Prior authorization is a requirement imposed by insurance companies and pharmacy benefit managers (PBMs) that a prescriber obtain approval before a medication can be dispensed and paid for by the plan. The insurance company reviews clinical documentation to determine whether the medication meets its coverage criteria before agreeing to pay.

The PA process typically involves:

  1. The prescriber submits a PA request with clinical documentation
  2. The insurance company's pharmacy team reviews the request against their coverage criteria
  3. A decision is issued — approved, denied, or additional information requested
  4. If approved, the pharmacy can dispense the medication under insurance coverage
  5. If denied, the prescriber can appeal or choose an alternative medication

How Long Does PA Take?

Standard PA decisions can take 24 to 72 hours. Urgent PA requests may be processed faster, but there is no guarantee. Appeals of denied PAs can take weeks. For a patient in acute pain after a car accident, even a 24-hour delay is too long.

Common Medications That Require PA in PI Cases

The medications most likely to trigger PA requirements are:

Brand-Name Medications When Generics Exist

If the prescriber writes for a specific brand-name medication and a generic equivalent is available, most insurance plans require PA before covering the brand. Examples include:

  • Lyrica (pregabalin) — Though generics are now available, some prescribers still write for the brand
  • Celebrex (celecoxib) — Generic celecoxib is widely available
  • Brand-name gabapentin products like Gralise or Neurontin

Higher-Cost Medications

Insurance plans frequently require PA for medications above a certain cost threshold, including:

  • Extended-release formulations that cost more than immediate-release versions
  • Newer medications that have less expensive alternatives in the same class
  • Specialty medications with high per-unit costs

Controlled Substances

Some insurance plans require PA for:

  • Opioid prescriptions exceeding a certain quantity or duration
  • Opioid prescriptions for patients who have not tried non-opioid alternatives first
  • Benzodiazepines and other Schedule IV controlled substances
  • High-dose gabapentin prescriptions (in states where gabapentin is a controlled substance)

Compound Medications

Compound medications almost universally require PA because they are custom-prepared and priced individually. Insurance companies want to verify that a commercially available alternative is not appropriate before covering a compound.

Topical Medications

Certain topical pain medications, including brand-name lidocaine patches (Lidoderm) and prescription-strength diclofenac gel (Voltaren Gel), may require PA depending on the insurance plan.

Workaround Strategies

When a PI patient faces a PA requirement, there are several strategies to get medications faster:

Strategy 1: Therapeutic Substitution

The fastest workaround is often switching to a clinically equivalent medication that does not require PA. For example:

  • If brand-name Lyrica requires PA, switch to generic pregabalin
  • If a specific NSAID requires PA, switch to meloxicam or naproxen, which are on most plans' formularies without PA
  • If an extended-release formulation requires PA, use the immediate-release version with adjusted dosing

This strategy requires coordination between the pharmacist, prescriber, and patient to ensure the alternative is clinically appropriate.

Strategy 2: Urgent PA Request

When therapeutic substitution is not appropriate, the prescriber can submit an urgent PA request. Insurance companies are required to process urgent requests faster — typically within 24 hours. The key is to clearly document why the medication is urgently needed:

  • Acute pain following a traumatic injury
  • Patient has tried and failed alternative medications
  • Delay would result in clinical harm

Strategy 3: Prescriber Override or Emergency Supply

Many states allow pharmacies to dispense an emergency supply of a medication while a PA is being processed. This is typically a 72-hour supply — enough to bridge the gap until the PA decision is made. The pharmacist documents the emergency supply and the PA request in progress.

Strategy 4: Manufacturer Copay Cards and Patient Assistance

For expensive brand-name medications, manufacturers often offer copay assistance programs that reduce or eliminate the patient's out-of-pocket cost. While these programs do not eliminate the PA requirement, they can provide temporary access while the PA is processed.

[!KEY] PA delays in PI cases are not merely administrative inconveniences — they are documented barriers to care that, when preserved in the case file, explain treatment gaps and support the argument that the client's insurance coverage was inadequate to provide the care a physician ordered.

Strategy 5: Cash Pay at Negotiated Rates

Patients can sometimes bypass PA entirely by paying cash for the medication. Services like GoodRx can significantly reduce the cash price. However, this creates an out-of-pocket cost that the patient may not be able to afford — especially after an accident.

Strategy 6: Pharmacy Lien Programs — The PA Bypass

The most comprehensive solution for PI patients is enrollment in a pharmacy lien program like LienScripts. Here is why: pharmacy lien programs do not process prescriptions through insurance. The medication is dispensed under the lien arrangement, not through the patient's insurance plan.

No insurance claim means no prior authorization requirement.

When a patient fills a prescription through a lien program at zero upfront cost, the entire PA process is irrelevant. The prescription is filled based on the prescriber's order and the clinical pharmacist's review — not an insurance company's coverage criteria.

This is one of the most significant advantages of pharmacy lien programs for PI patients. It eliminates the single largest source of medication access delays.

[!NOTE] Emergency supply laws in many states allow pharmacies to dispense a 72-hour bridge supply while a PA is pending — ask the pharmacist about this option to prevent a gap while the approval process runs its course.

The Cost of PA Delays

PA delays are not just inconvenient — they have measurable consequences:

Treatment Gaps

When a prescription cannot be filled because of a PA requirement, the patient goes without medication. These treatment gaps can set back recovery and create documentation problems in the case.

Pain and Suffering

A patient in acute pain who has to wait 48 hours for a PA approval is suffering unnecessarily. This is particularly true for post-accident patients who need immediate pain control to function and participate in their recovery.

Prescriber Burden

The PA process consumes significant prescriber time. Doctors and their staff must complete PA forms, provide clinical documentation, and follow up on pending requests. This administrative burden reduces the time available for patient care.

Abandonment

Studies consistently show that a significant percentage of prescriptions requiring PA are never filled. The patient either gives up during the PA process, switches to an OTC alternative that may be less effective, or simply goes without. In the PI context, prescription abandonment creates treatment gaps and weakens the case.

What Attorneys Can Do

  1. Enroll clients in a pharmacy lien program early to bypass PA requirements entirely
  2. If insurance is being used, educate clients about their right to emergency supplies and urgent PA processing
  3. Document any PA-related delays in the case file — they demonstrate the real-world impact of the injury on the client's life
  4. Work with the prescriber's office to ensure PA requests are submitted promptly and completely
  5. Consider PA delays as evidence of the barriers to medication access that your client faced

Prior authorization is a reality of the American healthcare system, but it does not have to be a barrier for personal injury patients. By understanding the workarounds available and leveraging pharmacy lien programs that bypass insurance entirely, attorneys can ensure their clients receive timely medication access from day one.

[!KEY] Compound medications, specialty agents, and controlled substances at higher doses are the most common PA triggers in PI cases — identifying these medications at intake and routing them through a pharmacy lien program from the start eliminates the PA process entirely for those prescriptions.

For more information about how LienScripts eliminates medication access barriers, visit our attorney resources page.

Related Resources

Frequently Asked Questions

How do pharmacy liens bypass prior authorization requirements?

Pharmacy lien programs bypass prior authorization entirely because they do not process prescriptions through health insurance. Prior authorization is an insurance requirement — when a lien-based program pays for the medication independently of any insurer, there is no insurance claim and therefore no PA requirement. The prescription is filled based on the treating physician's order and a clinical pharmacist's review, not an insurer's formulary criteria.

What medications commonly require prior authorization in PI cases?

Medications that frequently require prior authorization in personal injury cases include brand-name medications with available generics (such as Lyrica), extended-release formulations, higher-dose gabapentin, compound medications, controlled substances prescribed beyond standard quantities, and prescription-strength topicals like lidocaine patches. Any medication the insurer classifies as non-preferred or high-cost may trigger a PA requirement.

Can a pharmacy dispense medication while PA is pending?

Many states allow pharmacies to dispense an emergency supply of medication while a prior authorization is being processed — typically a 72-hour supply. This bridge supply gives the patient access while the PA decision is made. The pharmacist documents the emergency supply and the pending PA request. If the PA is ultimately denied, an appeal or therapeutic substitution is the next step.

How long does prior authorization take for accident medications?

Standard prior authorization decisions take 24 to 72 hours for personal injury medications. Urgent PA requests — where a prescriber documents acute clinical need — may be processed within 24 hours, though approval is not guaranteed. Appeals of denied PA decisions can take weeks. For patients in acute post-accident pain, even a 24-hour delay can be clinically significant and damaging to treatment continuity.

Does therapeutic substitution solve prior authorization denials?

Therapeutic substitution — switching to a clinically equivalent medication that does not require PA — is often the fastest workaround for prior authorization denials in personal injury cases. If brand-name Lyrica requires PA, generic pregabalin typically does not. If a specific NSAID requires PA, meloxicam or naproxen may be covered without restriction. Substitution requires coordination between the pharmacist, prescriber, and patient.